Downregulation of Rab25 activates Akt1 in head and neck squamous cell carcinoma

Seven,Didem; Dogan,Soydan; Kiliç,Erkan; Karaman,Emin; Koseoglu,Hikmet; Buyru,Nur

doi:10.3892/ol.2015.3433

Downregulation of Rab25 activates Akt1 in head and neck squamous cell carcinoma

Authors:
- Didem Seven
- Soydan Dogan
- Erkan Kiliç
- Emin Karaman
- Hikmet Koseoglu
- Nur Buyru
View Affiliations

Affiliations: Department of Medical Biology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul 34098, Turkey, Department of Otorhinolaryngology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul 34098, Turkey
Published online on: June 29, 2015 https://doi.org/10.3892/ol.2015.3433
Pages: 1927-1931

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Several studies have suggested that Ras-associated binding 25 protein (Rab25) is involved in the pathogenesis of human cancer. Although it has been demonstrated that the development of head and neck squamous cell carcinoma (HNSCC) is the result of an accumulation of multiple sequential genetic and epigenetic alterations in key genes with important functions in cell growth and the cell cycle, recent studies have indicated that HNSCC is a complex and heterogenous disease. To the best of our knowledge, there is no data regarding the regulation of the Rab25 gene at the mRNA or protein level in HNSCC. Furthermore, available data on Rab25 expression in other types of cancer are conflicting. The aim of the present study was to investigate whether Rab25 is involved in the development and/or progression of HNSCC, and to analyze the mechanisms underlying its effects in this type of cancer. The expression of Rab25 mRNA in HNSCC tissues and adjacent non‑tumor tissue samples was measured using reverse transcription‑quantitative polymerase chain reaction, while the level of the Rab25, Akt1 and phosphorylated‑Akt1 proteins was measured using western blotting. Expression of Rab25 mRNA and protein was downregulated in 69.1% and 56.1% of tumor tissue samples, respectively. This downregulation was associated with an increase in p‑Akt1 expression, in the absence of a change in total Akt1 protein levels, in tumor tissues compared with normal tissues. The current findings suggest that Rab25 acts as a tumor suppressor in HNSCC.

View Figures

View References

1	Warnakulasuriya S: Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009. View Article : Google Scholar : PubMed/NCBI
2	Hashibe M, Brennan P, Chuang SC, et al: Interaction between tobacco and alcohol use and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 18:541–550. 2009. View Article : Google Scholar : PubMed/NCBI
3	Howlader N, Noone AM, Krapcho M, et al: SEER Cancer Statistics Review, 1975–2010. National Cancer Institute; Bethesda, MD: http://seer.cancer.gov/csr/1975_2010/based on November 2012 SEER data submission, posted to the SEER web site. April. 2013
4	Báez A: Genetic and enviromental factors in head and neck cancer genesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 26:174–200. 2008. View Article : Google Scholar : PubMed/NCBI
5	Gleich LL and Salamone FN: Molecular genetics of head and neck cancer. Cancer Control. 9:369–378. 2002.PubMed/NCBI
6	Demokan S, Suoglu Y, Demir D, et al: Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer. Ann Oncol. 17:995–999. 2006. View Article : Google Scholar : PubMed/NCBI
7	Pereira-Leal JB and Seabra MC: Evolution of the Rab family of small GTP-binding proteins. J Mol Biol. 313:889–901. 2001. View Article : Google Scholar : PubMed/NCBI
8	Zerial M and McBride H: Rab proteins as membrane organizers. Nat Rev Mol Cell Biol. 2:107–117. 2001. View Article : Google Scholar : PubMed/NCBI
9	Deneka M, Neeft M and van der Sluijs P: Regulation of membrane transport by rab GTPases. Crit Rev Biochem Mol Biol. 38:121–142. 2003. View Article : Google Scholar : PubMed/NCBI
10	Pfeffer S and Aivazian D: Targeting Rab GTPases to distinct membrane compartments. Nat Rev Mol Cell Biol. 5:886–896. 2004. View Article : Google Scholar : PubMed/NCBI
11	Jordens I, Marsman M, Kuijl C and Neefjes J: Rab proteins, connecting transport and vesicle fusion. Traffic. 6:1070–1077. 2005. View Article : Google Scholar : PubMed/NCBI
12	Schwartz SL, Cao C, Pylypenko O, Rak A and Wandinger-Ness A: Rab GTPases at a glance. J Cell Sci. 120:3905–3910. 2007. View Article : Google Scholar : PubMed/NCBI
13	Somsel Rodman J and Wandinger-Ness A: Rab GTPases coordinate endocytosis. J Cell Sci 113 Pt. 2:183–92. 2000.
14	Vetter IR and Wittinghofer A: The guanine nucleotide-binding switch in three dimensions. Science. 294:1299–1304. 2001. View Article : Google Scholar : PubMed/NCBI
15	Goldenring JR, Shen KR, Vaughan HD and Modlin IM: Identification of a small GTP-binding protein, Rab25, expressed in the gastrointestinal mucosa, kidney and lung. J Biol Chem. 268:18419–18422. 1993.PubMed/NCBI
16	He H, Dai F, Yu L, et al: Identification and characterization of nine novel human small GTPases showing variable expressions in liver cancer tissues. Gene Expr. 10:231–242. 2002.PubMed/NCBI
17	Casanova JE, Wang X, Kumar R, et al: Association of Rab25 and Rab11a with the apical recycling system of polarized Madin-Darby canine kidney cells. Mol Biol Cell. 10:47–61. 1999. View Article : Google Scholar : PubMed/NCBI
18	Wang X, Kumar R, Navarre J, et al: Regulation of vesicle trafficking in madin-darby canine kidney cells by Rab11a and Rab25. J Biol Chem. 275:29138–29146. 2000. View Article : Google Scholar : PubMed/NCBI
19	Agarwal R, Jurisica I, Mills GB and Cheng KW: The emerging role of the RAB25 small GTPase in cancer. Traffic. 10:1561–1568. 2009. View Article : Google Scholar : PubMed/NCBI
20	Cheng KW, Lahad JP, Gray JW and Mills GB: Emerging role of RAB GTPases in cancer and human disease. Cancer Res. 65:2516–2519. 2005. View Article : Google Scholar : PubMed/NCBI
21	Mitra S, Cheng KW and Mills GB: Rab25 in cancer: A brief update. Biochem Soc Trans. 40:1404–1408. 2012. View Article : Google Scholar : PubMed/NCBI
22	Cheng KW, Lahad JP, Kuo WL, et al: The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med. 10:1251–1256. 2004. View Article : Google Scholar : PubMed/NCBI
23	Fan Y, Xin XY, Chen BL and Ma X: Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo. Pathology. 38:561–567. 2006. View Article : Google Scholar : PubMed/NCBI
24	Liu Y, Tao X, Jia L, et al: Knockdown of RAB25 promotes autophagy and inhibits cell growth in ovarian cancer cells. Mol Med Rep. 6:1006–1012. 2012.PubMed/NCBI
25	Zhang J, Wei J, Lu J, et al: Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling. Carcinogenesis. 34:2401–2408. 2013. View Article : Google Scholar : PubMed/NCBI
26	Calvo A, Xiao N, Kang J, et al: Alterations in gene expression profiles during prostate cancer progression: Functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Res. 62:5325–5335. 2002.PubMed/NCBI
27	Wang W, Goswami S, Lapidus K, et al: Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res. 64:8585–8594. 2004. View Article : Google Scholar : PubMed/NCBI
28	Mor O, Nativ O, Stein A, et al: Molecular analysis of transitional cell carcinoma using cDNA microarray. Oncogene. 22:7702–7710. 2003. View Article : Google Scholar : PubMed/NCBI
29	Natrajan R, Williams RD, Hing SN, et al: Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. J Pathol. 210:49–58. 2006. View Article : Google Scholar : PubMed/NCBI
30	Cheng JM, Ding M, Aribi A, et al: Loss of RAB25 expression in breast cancer. Int J Cancer. 118:2957–2964. 2006. View Article : Google Scholar : PubMed/NCBI
31	Goldenring JR and Nam KT: Rab25 as a tumour suppressor in colon carcinogenesis. Br J Cancer. 104:33–36. 2011. View Article : Google Scholar : PubMed/NCBI
32	Amornphimoltham P, Rechache K, Thompson J, et al: Rab25 regulates invasion and metastasis in head and neck cancer. Clin Cancer Res. 19:1375–1388. 2013. View Article : Google Scholar : PubMed/NCBI
33	Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
34	Grosshans BL, Ortiz D and Novick P: Rabs and their effectors: Achieving specificity in membrane traffic. Proc Natl Acad Sci USA. 103:11821–11827. 2006. View Article : Google Scholar : PubMed/NCBI
35	Cheng KW, Lu Y and Mills GB: Assay of Rab25 function in ovarian and breast cancers. Methods Enzymol. 403:202–215. 2005. View Article : Google Scholar : PubMed/NCBI
36	Sheach LA, Adeney EM, Kucukmetin A, et al: Androgen-related expression of G-proteins in ovarian cancer. Br J Cancer. 101:498–503. 2009. View Article : Google Scholar : PubMed/NCBI
37	Tong M, Chan KW, Bao JY, et al: Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma. Cancer Res. 72:6024–6035. 2012. View Article : Google Scholar : PubMed/NCBI
38	Cheng JM, Volk L, Janaki DK, Vyakaranam S, Ran S and Rao KA: Tumor suppressor function of Rab25 in triple-negative breast cancer. Int J Cancer. 126:2799–2812. 2010.PubMed/NCBI
39	Bigelow RL, Williams BJ, Carroll JL, et al: TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro. Breast Cancer Res Treat. 117:31–44. 2009. View Article : Google Scholar : PubMed/NCBI
40	Cheng KW, Agarwal R, Mitra S, et al: Rab25 increases cellular ATP and glycogen stores protecting cancer cells from bioenergetic stress. EMBO Mol Med. 4:125–141. 2012. View Article : Google Scholar : PubMed/NCBI
41	Caswell PT, Spence HJ, Parsons M, White DP, Clark K, Cheng KW, Mills GB, Humphries MJ, Messent AJ, Anderson KI, et al: Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments. Dev Cell. 13:496–510. 2007. View Article : Google Scholar : PubMed/NCBI
42	Lapierre LA, Caldwell CM, Higginbotham JN, Avant KM, Hall J, Beauchamp RD and Goldenring JR: Transformation of rat intestinal epithelial cells by overexpression of Rab25 is microtubule dependent. Cytoskeleton (Hoboken). 68:97–111. 2011. View Article : Google Scholar : PubMed/NCBI
43	Tang BL: Is Rab25 a tumor promoter or suppressor-context dependency on RCP status? Tumor Biol. 31:359–361. 2010. View Article : Google Scholar